TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
SEER

Seer Inc

Healthcare · Biotechnology

1.90$ -3.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement SEER
Line item 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
604.3% 244.8% 105.8% 97.4% 90.5% 51.0% 50.3%
-504.3% -144.8% -5.8% 2.6% 9.5% 49.0% 49.7%
10,079.3% 2,642.7% 455.4% 311.9% 312.5% 362.7% 272.2%
3,970.7% 2,341.9% 715.7% 398.6% 398.5% 405.6% 264.2%
14,050.0% 4,984.6% 1,115.5% 670.3% 700.8% 766.7% 533.5%
-14,554.3% -5,129.4% -1,121.3% -667.6% -691.2% -717.7% -483.9%
4.3% 1.4% 0.3% 2.2%
-13,825.9% -4,996.2% -1,113.1% -633.1% -568.3% -620.2% -455.4%
4.3% -244.8% -39.7% -29.1% 35.6% 0.7% 1.2%
-13,825.9% -4,996.2% -1,113.1% -633.1% -568.3% -620.9% -456.6%
-13,217.2% -4,751.4% -1,057.3% -592.9% -531.5% -575.9% -446.0%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?